A carregar...
Novel CD20 monoclonal antibodies for lymphoma therapy
Rituximab (RTX), a monoclonal antibody (mAb) against CD20, has been widely used for lymphoma therapy. RTX in combination with cyclophosphamide /doxorubicin /vincristine /prednisone (R-CHOP) remains the standard frontline regimen for diffuse large B-cell lymphoma. However, suboptimal response and /or...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3479003/ https://ncbi.nlm.nih.gov/pubmed/23057966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-5-64 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|